ConductScience.org, home

Paper23364441

Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.

French MA and 9 others. AIDS, 2013. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers. Papers, record 23364441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23364441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
PubMed
Journal
AIDS
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2013-01-31
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1French MAMartyn A
2Center RJRob J
3Wilson KMKim M
4Fleyfel IIbrahim
5Fernandez SSonia
6Schorcht AAnna
7Stratov IIvan
8Kramski MMarit
9Kent SJStephen J
10Kelleher ADAnthony D

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adaptive ImmunityMajor topic
CD8-Positive T-LymphocytesMajor topic
HIV SeropositivityMajor topic
Immunoglobulin GMajor topic
Killer Cells, NaturalMajor topic
Lymphocyte ActivationMajor topic
gag Gene Products, Human Immunodeficiency VirusMajor topic
Alleles
Blotting, Western
Disease Progression
Enzyme-Linked Immunosorbent Assay
Female
Host-Pathogen Interactions
Humans
Male
RNA, Viral
Receptors, IgG
Viral Load
Virus Replication

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
39288118Identification of antibody targets associated with lower HIV viral load and viremic control.PLoS One2024https://conductscience.org/library/papers/39288118PubMed
34717659Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.Retrovirology2021https://conductscience.org/library/papers/34717659PubMed
33328567Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4+/CD8+ T cells and humoral responses in macaques.Sci Rep2020https://conductscience.org/library/papers/33328567PubMed
32733445Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women.Front Immunol2020https://conductscience.org/library/papers/32733445PubMed
31048360Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection.Mol Syst Biol2019https://conductscience.org/library/papers/31048360PubMed
30952887Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques.Sci Rep2019https://conductscience.org/library/papers/30952887PubMed
30534128Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection.Front Immunol2018https://conductscience.org/library/papers/30534128PubMed
30153293Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.PLoS One2018https://conductscience.org/library/papers/30153293PubMed
29794117Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity.J Exp Med2018https://conductscience.org/library/papers/29794117PubMed
29630668HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.PLoS Pathog2018https://conductscience.org/library/papers/29630668PubMed
29581149High-resolution definition of humoral immune response correlates of effective immunity against HIV.Mol Syst Biol2018https://conductscience.org/library/papers/29581149PubMed
29560282Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-γ.NPJ Vaccines2018https://conductscience.org/library/papers/29560282PubMed
29326728Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.Front Immunol2017https://conductscience.org/library/papers/29326728PubMed
28830571Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.Retrovirology2017https://conductscience.org/library/papers/28830571PubMed
28725225Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Front Immunol2017https://conductscience.org/library/papers/28725225PubMed
28629910Memory B Cells, the HLA-B*57 Allele and Natural Control of HIV Infection.EBioMedicine2017https://conductscience.org/library/papers/28629910PubMed
28615147HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.EBioMedicine2017https://conductscience.org/library/papers/28615147PubMed
28604502Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers.J Acquir Immune Defic Syndr2017https://conductscience.org/library/papers/28604502PubMed
26813340Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.Mucosal Immunol2016https://conductscience.org/library/papers/26813340PubMed
26433697Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?Trends Microbiol2015https://conductscience.org/library/papers/26433697PubMed

See all 27 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23364441

GET https://conductscience.org/api/papers/v1/23364441/cited_by?page=2